Drawing for CUREON

USPTO serial 76038881

CUREON

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
DEFORD, JEFFREY S
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CUREON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia Clarke Weber

CYNTHIA CLARKE WEBER SUGHRUE, MION, ZINN, MACPEAK & SEAS2100 PENNSYLVANIA AVE N WWASHINGTON, DC 20037UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001CHEMICALS USED IN THE MANUFACTURE OF RESEARCH TOOLS, DRUG DISCOVERY TOOLS, DRUGS CANDIDATES AND DRUGS FOR USE IN THE PHARMACEUTICAL, BIOTECHNOLOGICAL, AND VETERINARY INDUSTRY AND SCIENCE; CHEMICAL REAGENTS FOR SCIENTIFIC AND RESEARCH USE; CHEMICAL SUBSTANCES FOR LABORATORY ANALYSIS USE IN RESEARCH AND DEVELOPMENT; CHEMICALS FOR USE AS A RESEARCH TOOL FOR SCIENTIFIC AND RESEARCH USE, NONE OF THE FOREGOING GOODS BEING GASTROINTESTINAL PREPARATIONS NOT INCLUDING GASTROINTESTINAL PREPARATIONSACTIVE
005PHARMACEUTICAL AND VETERINARY PREPARATIONS, NAMELY FOR THE TREATMENT OF CANCER, INFLAMMATORY DISEASES, IMMUNOLOGY DISEASES, INFECTIOUS DISEASES, DIABETES, HYPERTENSION AND DEPRESSION, MUSCOSKELETAL DISEASES, CARDIOLOGICAL AND VASCULAR DISEASES AND DISORDERS, PULMONARY AND RESPIRATORY DISEASES, ENDOCRINE DISEASES AND DISORDERS, HEMATOLOGICAL DISEASES, NEPHROLOGICAL AND UROLOGICAL DISEASES, NEUROLOGICAL DISEASES, OPHTHALMOLOGICAL DISEASES, OTOLARYNGOLOGICAL DISEASES, RHEUMATOLOGICAL DISEASES AND DISEASES AND CONDITIONS RELATED TO TRAUMA AND EMERGENCY; CHEMICO-PHARMACEUTICAL PREPARATIONS FOR PHARMACEUTICAL, MEDICAL, VETERINARY AND THERAPEUTIC PURPOSES, NAMELY FOR TREATING CANCER, INFLAMMATORY DISEASES, IMMUNOLOGY DISEASES, INFECTIOUS DISEASES, DIABETES, HYPERTENSION AND DEPRESSION, MUSCOSKELETAL DISEASES, CARDIOLOGICAL AND VASCULAR DISEASES AND DISORDERS, PULMONARY AND RESPIRATORY DISEASES, ENDOCRINE DISEASES AND DISORDERS, GASTROENTEROLOGICAL DISEASES, HEMATOLOGICAL DISEASES, NEPHROLOGICAL AND UROLOGICAL DISEASES, NEUROLOGICAL DISEASES, OPHTHALMOLOGICAL DISEASES, OTOLARYNGOLOGICAL DISEASES, RHEUMATOLOGICAL DISEASES AND DISEASES AND CONDITIONS RELATED TO TRAUMA AND EMERGENCY; CHEMICAL REAGENTS FOR CLINICAL MEDICAL, VETERINARY AND THERAPEUTIC PURPOSES; PHARMACEUTICAL PREPARATIONS, NAMELY DRUGS AND DRUG CANDIDATES FOR MEDICAL, VETERINARY AND THERAPEUTIC PURPOSES FOR TREATING CANCER, INFLAMMATORY DISEASES, IMMUNOLOGY DISEASES, INFECTIOUS DISEASES, DIABETES, HYPERTENSION AND DEPRESSION, MUSCOSKELETAL DISEASES, CARDIOLOGICAL AND VASCULAR DISEASES AND DISORDERS, PULMONARY AND RESPIRATORY DISEASES, ENDOCRINE DISEASES AND DISORDERS, HEMATOLOGICAL DISEASES, NEPHROLOGICAL AND UROLOGICAL DISEASES, NEUROLOGICAL DISEASES, OPHTHALMOLOGICAL DISEASES, OTOLARYNGOLOGICAL DISEASES, RHEUMATOLOGICAL DISEASES AND DISEASES AND CONDITIONS RELATED TO TRAUMA AND EMERGENCY; NON OF THE FOREGOING GOODS BEING FOR GASTROINTESTINAL PREPARATIONSACTIVE
042RESEARCH AND DEVELOPMENT IN THE FIELD OF DRUG DISCOVERY, DRUG DEVELOPMENT, TARGET VALIDATION AND SCIENCE; PROFESSIONAL CONSULTANCY IN THE FIELD OF CHEMICAL ANALYSIS AND RESEARCH, BIOLOGICAL ANALYSIS AND RESEARCH, BIOCHEMICAL ANALYSIS AND RESEARCH, BIOLOGICAL ANALYSIS AND RESEARCH AND MOLECULAR BIOLOGY ANALYSIS AND RESEARCH; PATENT EXPLOITATION, NAMELY LICENSING OF CHEMICAL ANALYSIS, PROCESSES, MEDICAL, DIAGNOSTIC AND THERAPEUTIC TREATMENT PATENTS, CHEMICAL ANALYSIS AND RESEARCH; ANALYSIS OF THERAPEUTICAL EFFECTS OF CHEMICAL, PHARMACEUTICAL, MEDICAL AND VETERINARY PREPARATION; TARGET VALIDATION SERVICES AND CONSULTING; NONE OF THE FOREGOING SERVICES BEING IN THE FIELD OF GASTROINTESTINAL PREPARATIONSACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 26, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 26, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 12, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 18, 2004ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 28, 2004FAXXFAX RECEIVED
Dec 4, 2002ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Oct 22, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 2, 2002NPUBNOTICE OF PUBLICATION
Jul 22, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2001CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 23, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2000DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance